Quantcast

Endo Pharmaceuticals Testosterone Therapy Faces Lawsuit

Endo Pharmaceuticals Testosterone Therapy Drug Fortesta Faces Product Liability Lawsuit Endo Pharmaceuticals and the Prostrakan Group PLC were hit with a product liability lawsuit in a Pennsylvania court in early May for their testosterone therapy gel, Fortesta.  The lawsuit claims that the company failed to disclose serious and dangerous side … [Read more...]

Endocrine Society Calls for Longer Studies on Testosterone Therapy

As FDA Declares It Will Study Testosterone Therapy, Endocrine Society Calls for Longer, More Thorough Studies of the Drug At the end of January of this year, the Food and Drug Administration (FDA) said that it would investigate claims that testosterone therapy approved by the agency could lead to serious heart conditions in users, including … [Read more...]

Testosterone Therapy Drugs Should Carry Warning

Consumer Group Advocates for Black Box Warning Label on Testosterone Therapy A consumer advocacy group is petitioning the FDA to put a black box warning, the strongest warning label possible, on testosterone therapy drugs due to the potential for heart problems or stroke. Public Citizen added that the FDA should also require testosterone therapy … [Read more...]

FDA Warns Against Overuse of Testosterone Therapy

Another Warning from the FDA Chides Doctors for Over-Prescribing and Enabling Overuse of Testosterone Therapy The Food and Drug Administration has issued another warning to doctors regarding overuse of testosterone replacement therapy – the gels, pills, and ointments, the agency says, should not be overused to treat common signs of aging, such as … [Read more...]

AndroGel Lawsuits Allege Company Hid Dangers

AndroGel Testosterone Therapy Lawsuits Allege Manufacturer Hid Dangers from Consumers Five men have filed personal injury lawsuits against the testosterone replacement drug, AndroGel, alleging that the company hid the cardiovascular dangers of the drug. The complaints were filed in the federal court of Chicago on February 5th, just a few days … [Read more...]

AndroGel’s Testosterone Therapy Lawsuits Consolidated

AndroGel Testosterone Therapy Lawsuits Consolidated The Judicial Panel on Multidistrict Litigation (JPML) issued an order on June 6th to consolidate testosterone therapy injury lawsuits involving Abbott Laboratories and Abbvie, Inc testosterone gels.  Testosterone therapy drugs including AndroGel are believed to increase the risk of heart attacks … [Read more...]

FDA to Investigate Heart Problems with Testosterone Therapy

FDA Will Investigate Approved Testosterone Therapies for Heart Link The Food and Drug Administration (FDA) issued a statement on Friday, January 31st, that the agency will investigate reported risks for heart attack and stroke associated with testosterone therapy. The statement was spurred by two recently published studies involving low … [Read more...]

Testosterone Therapy Increases Risk of Heart Disease, Stroke

Studies Show Link Between Testosterone Therapy in Men and Heart Failure, Disease, and Stroke Risk Several studies in the past year show a link between testosterone therapy treatments and an increased risk in men of heart failure, disease, and stroke. Testosterone therapy, especially in the form of gels, patches, and injections, have been … [Read more...]

FDA Enforces Warning Labels on Testosterone Therapy

FDA Requires Warnings on Testosterone Therapy About Blood Clots On Thursday, June 19th, the Food and Drug Administration (FDA) announced that it would require warning labels on testosterone therapy, including AndroGel, that would inform consumers about the risks of blood clots and strokes. Postmarket studies of blood clot and stroke risks related … [Read more...]

FDA Advises Testosterone Therapy Not Good for “Low T”

FDA Panel Advises Testosterone Therapy for “Low T” Needs Further Investigation When the Food and Drug Administration originally approved some types of testosterone therapy, the intended use was to treat serious hormonal disorders, such as hypogonadism. Despite this limited approval, pharmaceutical companies heavily marketed the claim that … [Read more...]

BestLawyers.comAVBetter Business Bureau